CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-25 | Smith David Ross Corporate Executive VP & CFO | Gift | +8,656 | 8,656 | ||
| 2021-01-14 | FOSTER JAMES C Chairman, President and CEO | Gift | −3,500 | 214,793 | ||
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −531 | $243.71 | $129K | 20,236 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −165 | $244.94 | $40K | 20,071 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −264 | $245.57 | $65K | 19,807 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −535 | $246.76 | $132K | 19,272 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −756 | $247.89 | $187K | 18,516 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −935 | $248.84 | $233K | 17,581 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −531 | $249.97 | $133K | 17,050 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −133 | $250.87 | $33K | 16,917 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −426 | $251.90 | $107K | 16,491 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −303 | $252.99 | $77K | 16,188 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −310 | $253.88 | $79K | 15,878 |
| 2021-01-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −111 | $254.77 | $28K | 15,767 |
| 2020-12-01 | LaPlume Joseph W EVP, Corp Strategy & Develop | Gift | −310 | 11,046 | ||
| 2020-11-13 | FOSTER JAMES C Chairman, President and CEO | Gift | −4,706 | 0 | ||
| 2020-11-04 | LaPlume Joseph W EVP, Corp Strategy & Develop | Option exercise | +492 | $88.05 | $43K | 11,848 |
| 2020-11-04 | LaPlume Joseph W EVP, Corp Strategy & Develop | Option exercise | +3,205 | $109.34 | $350K | 15,053 |
| 2020-11-04 | LaPlume Joseph W EVP, Corp Strategy & Develop | Option exercise | +3,042 | $144.67 | $440K | 18,095 |
| 2020-11-04 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −2,639 | $249.09 | $657K | 15,456 |
Page 49 of 60 · 1,185 trades